1129540-33-5 Usage
Uses
Used in Cancer Research and Treatment:
PACLITAXEL-D5 is used as an antineoplastic agent for the study and treatment of various types of cancer. It plays a crucial role in understanding the structure and function of microtubules, which are essential components of the cell's cytoskeleton and are involved in cell division and growth.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, PACLITAXEL-D5 is used as a labeled compound to facilitate the study of microtubule dynamics and their role in cancer cell proliferation. This knowledge aids in the development of novel therapeutic strategies and drug delivery systems to target cancer cells more effectively.
Used in Drug Development:
PACLITAXEL-D5 is also used in drug development to test the efficacy of new compounds against cancer cells. Its antineoplastic properties make it a valuable tool for evaluating the potential of new drugs in inhibiting cancer cell growth and inducing cell death.
Used in Diagnostic Applications:
In diagnostic applications, PACLITAXEL-D5 can be used as a labeled compound to visualize and study the microtubule network in cells, providing insights into the cellular processes involved in cancer development and progression. This information can be instrumental in the early detection and diagnosis of various types of cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 1129540-33-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,9,5,4 and 0 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1129540-33:
(9*1)+(8*1)+(7*2)+(6*9)+(5*5)+(4*4)+(3*0)+(2*3)+(1*3)=135
135 % 10 = 5
So 1129540-33-5 is a valid CAS Registry Number.
1129540-33-5Relevant academic research and scientific papers
Synthesis of deuterium-labelled paclitaxel and its hydroxyl metabolite
Tian, Lei,Wu, Keying,Tao, Jie,Chen, Liqin
, p. 318 - 323 (2012/02/03)
This paper describes the synthesis of deuterium-labelled paclitaxel and its hydroxyl metabolite. Paclitaxel labelled with 2H was obtained in four steps using the commercially available [2H5]benzoic chloride as the stable l